@article {Cholankeril2020.04.23.20076935, author = {George Cholankeril and Alexander Podboy and Vasiliki Irene Aivaliotis and Edward A. Pham and Sean Spencer and Donghee Kim and Ann Hsing and Aijaz Ahmed}, title = {Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection}, elocation-id = {2020.04.23.20076935}, year = {2020}, doi = {10.1101/2020.04.23.20076935}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background High rates of concurrent gastrointestinal manifestations have been noted in patients with COVID-19, however the association between these digestive manifestations and need for hospitalization has not been established.Methods Following expedited approval from our Institutional Review Board, we analyzed retrospectively collected data from consecutive patients with confirmed COVID-19 based on a positive polymerase chain reaction testing at our institution from March 03, 2020 to April 7, 2020. Baseline demographic, clinical, laboratory and patient-reported symptom data were collected at presentation in the emergency room. Multivariable logistic regression analyses were performed to evaluate the association between hospitalization and presence of gastrointestinal symptoms.Results During this study period, we identified 207 consecutive patients with confirmed COVID-19. 34.5\% noted concurrent gastrointestinal symptoms; of which 90\% of gastrointestinal symptoms were mild. In a multivariate regression model controlled for demographics and disease severity, an increased risk for hospitalization was noted in patients with any gastrointestinal symptom (adjusted OR 4.84 95\% CI: 1.68-13.94]. Diarrhea was associated with a seven-fold higher likelihood for hospitalization (adjusted OR=7.58, 95\% CI: 2.49-20.02, P \<0.001) and nausea or vomiting had a four times higher odds. (adjusted OR 4.39, 95\% CI: 1.61-11.4, P = 0.005).Conclusion We demonstrate that a significant portion of COVID19 patients have concurrent mild gastrointestinal symptoms and that the presence of these digestive symptoms is associated with a need for hospitalization. With the current focus on streamlining triaging efforts, first responders and frontline providers should consider assessing for digestive symptoms in their initial clinical evaluation and decision-making.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. Cholankeril, Dr. Pham, Dr. Tarlow and Dr. Spencer are supported in part by the NIH Training Grant T32DK007056.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated analysed during the current study are not publicly available due to IRB restraints but are available from the corresponding author on reasonable request.}, URL = {https://www.medrxiv.org/content/early/2020/04/28/2020.04.23.20076935}, eprint = {https://www.medrxiv.org/content/early/2020/04/28/2020.04.23.20076935.full.pdf}, journal = {medRxiv} }